Corey Davis, J.D., M.S.P.H., is deputy director of the Network’s Southeastern Region Office and  Director of the Harm Reduction Legal Project. Corey was previously a Senior Attorney at the National Health Law Program (NHeLP), where he helped to advance access to quality health care for low-income and underserved individuals. Before joining NHeLP Corey served as Employment Rights Attorney at Equality Advocates Pennsylvania, where he represented lesbian, gay, bisexual and transgender (LGBT) individuals before administrative commissions and in state and federal courts. He previously oversaw a street-based legal clinic sited at Philadelphia’s syringe exchange program.

Corey has served as chair of a county board of health, chair of the board of the North Carolina Harm Reduction Coalition, and vice-chair of the North Carolina Harm Public Health Foundation, among other positions. He is a recipient of the International AIDS Society’s Young Investigator Award andhas published extensively in the lay and academic press. Corey received his B.S. from the Indiana University of Pennsylvania, his M.S.P.H. from the University of North Carolina at Chapel Hill and his J.D. from Temple University. Corey is barred in Pennsylvania and New Jersey as well as various federal courts.

View a collection of research, resources and trainings produced by Corey below.

Articles & Resources

Indian Health Service and Military Medical Prescription Drug Monitoring Program Requirements

Fact SheetSubstance Use Prevention and Harm ReductionOpioid Misuse and Overdose PreventionTribal Health

April 25, 2018
by Corey Davis

Prescription Drug Monitoring Programs (PDMPs) are state-run databases that collect information on specified medications at the point of dispensing. The data is available to medical professionals and others, as permitted by relevant law. PDMPs can help clinicians improve decisions regarding opioid prescribing.

View page

Litigation Against Opioid Manufacturers: Lessons from the Tobacco Wars

WebinarsOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

March 15, 2018
by Corey Davis

Dozens of state, local, and tribal governments have sued opioid pain reliever manufacturers for their alleged role in fueling the opioid overdose epidemic, and 41 state attorneys general are investigating potential unlawful sales and marketing practices by these manufacturers. Although these investigations and lawsuits appear similar to those against the tobacco industry during the 1990s, states should mindful of the important ways in which they differ.

View page

Public Health Emergency Declaration Falls Short of Expanding Access to Opioid Use Disorder Treatment in Rural Communities

Law & Policy InsightsPublic Health Emergency: Legal Preparedness & Response

January 8, 2018
by Corey Davis

The number of Americans affected by the opioid epidemic has reached staggering rates. In 2016, more Americans died from drug overdoses than died through the entirety of the Vietnam War. Fortunately, there is an effective, evidence-based way of treating opioid use disorder (OUD) – treatment with the medications methadone and buprenorphine, which is termed medication-assisted treatment (MAT).

Read more

The Negative Impacts of Eliminating ACA Cost-Sharing Reduction Payments

Law & Policy InsightsHealth Reform

December 15, 2017
by Corey Davis

Nearly 4.7 million Americans, including 1.3 million new enrollees, signed up for health care through the Affordable Care Act’s marketplaces, and polling indicates the public has a favorable opinion of the law. Nevertheless, after failing in their full-scale attempt to repeal and replace the Affordable Care Act (ACA), Congressional Republicans and the Trump Administration continue to put individual pieces of the legislation at risk of elimination.

Read more

From 0 to 50: The Rapid Adoption of Naloxone Access Laws in the U.S.

Law & Policy InsightsSubstance Use Prevention and Harm ReductionOpioid Misuse and Overdose Prevention

July 26, 2017
by Corey Davis

The opioid overdose epidemic is a continuing public health crisis. When we began tracking laws aimed to increase access to naloxone in late 2012, they existed in only eight states. As of July 1, 2017, every state and Washington D.C. has passed at least one law increasing access to naloxone—a remarkably rapid progression for public health legislation.

Read more

Action, Not Rhetoric, Needed to Reverse the Opioid Overdose Epidemic – Q&A

Law & Policy InsightsSubstance Use Prevention and Harm ReductionOpioid Misuse and Overdose Prevention

June 19, 2017
by Corey Davis

The recently released Journal of Law, Medicine & Ethics supplemental issue features articles authored by presenters at the Public Health Law Conference in Washington D.C. Corey Davis, deputy director at the Network for Public Health Law – Southeastern Region Office, co-authored the article, “Action, Not Rhetoric, Needed to Reverse the Opioid Overdose Epidemic.” In the following Q&A, Corey discusses his article and how it addresses a critical public health issue.

Read more